BioSpace News Archive

Teva Pharmaceutical Industries Ltd. announced that new data on AJOVY® and the burden of migraine in Europe will be presented at the 6th Congress of the European Academy of Neurology, being held virtually from 23-26 May 2020.

Oncopeptides AB announces a successful completion of enrollment in the pivotal phase 3 study OCEAN for the treatment of relapsed refractory multiple myeloma.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, provided a business update and reported financial results for the first quarter of 2020.

Luminex Corporation, announced that its board of directors declared a cash dividend for the second quarter of 2020 of $0.09 per share of common stock payable on July 9, 2020 to stockholders of record as of the close of business June 18, 2020.

Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating Assertio Therapeutics, Inc. (“Assertio Therapeutics” or the “Company”) (NasdaqGS: ASRT) relating to the creation of a combined company between the C

Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the first quarter ended March 31, 2020. First Quarter 2020 Highlights Net Revenues for the first quarter of 2020 decreased to $7.4 million compared to $13.1 million in the same quarter of the prior year. The $5.7 million decrease was driven primarily by a $3.8 million decrease in US Teligent label products relat

SmallCapVoice.com, Inc. (SCV) and Wuhan General Group, Inc. (OTC PINK: WUHN) (the “Company” and “Wuhan”), announced today that a new audio interview with the Company is now available. The interview featuring an overview of WUHN’s current news and moves can be heard at https://www.smallcapvoice.com/tag/wuhn/ . Jeff Robinson, CEO of Wuhan, called in to SmallCapVoice.com to go over the business model and markets that his Company operates in. Wuh

Intercept Pharmaceuticals, Inc. announced that based on discussions earlier this week, the U.S. Food and Drug Administration has notified Intercept that its tentatively scheduled June 9, 2020 advisory committee meeting relating to the company’s new drug application for obeticholic acid for the treatment of liver fibrosis due to nonalcoholic steatohepatitis has been postponed.

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) is a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions. As part of this program, the company is developing therapies for patients infected with the SARS-CoV-2 virus (“COVID-19").

Rebound hypoglycemia observed in the placebo arm with oral glucose tablet use; No rebound hypoglycemia observed in the RTU glucagon treatment arm CHICAGO--( BUSINESS WIRE )-- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced positive findings from the outpatient stage of a Phase 2